Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advised Lagardère Unlimited in connection with its taking over of the management of Friends Arena
Mandate

Vinge advised Lagardère Unlimited in connection with its taking over of the management of Friends Arena

January 27, 2015

Vinge advised Lagardère Unlimited (“Lagardère”) in connection with its acquisition of Driftbolaget i Solna AB and the entering into of a long term lease agreement with the real-estate owner of Friends Arena, Arenabolaget i Solna AB. Lagardère hereby takes over the management of Friends Arena for at least the next ten years.

Vinge’s team consisted of responsible partner Michael Wigge, counsel Ulrich Ziche, partner Karin Grauers and associates Sofie Bjärtun, Daniel Unger, Adriana Berglund, David Henningsson, Sofia Ekdahl, Matilda Gustafsson and Evelina Tejle.

Related

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

 Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026